Messerlian Carmen, Mustieles Vicente, Wylie Blair J, Ford Jennifer B, Keller Myra, Ye Xiaoyun, Calafat Antonia M, Williams Paige L, Hauser Russ
Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
University of Granada, Centro de Investigación Biomédica, Granada, Spain.
Int J Hyg Environ Health. 2017 Nov;220(8):1285-1294. doi: 10.1016/j.ijheh.2017.08.003. Epub 2017 Aug 14.
Systemic absorption of phthalates and parabens has been demonstrated after dermal application of body lotion, and medical devices such as intravenous bags and tubing have been identified as a source of exposure to di(2-ethylhexyl) phthalate (DEHP). However, use of products during medical procedures such as aqueous gel applied during obstetrical ultrasound in pregnancy has not been investigated as a potential source of endocrine disrupting chemical (EDC) exposure. Human studies have associated EDCs with various adverse pregnancy outcomes. There is a need to identify sources of inadvertent exposure to EDCs especially during vulnerable developmental periods such as pregnancy.
We conducted a pilot study to determine whether use of gel during routine obstetrical ultrasound increased urinary concentrations of phthalate and phenol biomarkers.
We recruited 13 women from the Massachusetts General Hospital who provided spot urine samples at the time of their second trimester anatomic survey. The first sample was collected prior to the procedure (pre-exposure, time 1), and two additional samples were obtained at approximately 1-2h (time 2) and 7-12h (time 3) post-exposure following the scan.
Urinary concentrations of several DEHP metabolites and metabolite of diisononyl cyclohexane-1,2-dicarboxylate (DINCH) increased across time. For example, the geometric mean concentrations of mono(2-ethyl-5-hydroxyhexyl) phthalate increased from 3.1ng/ml to 7.1ng/ml (p-value=0.03) between time 1 and time 3. We also observed significant differences in concentrations of metabolites of butylbenzyl phthalate (BBzP), di-n-butyl phthalate (DnBP), and di-isobutyl phthalate (DiBP). For example, mono-n-butyl phthalate (metabolite of DnBP) decreased from 3.5ng/ml to 1.8ng/ml (p-value=0.04) between time 1 and time 2, but then increased to 6.6ng/ml (p-value=0.002) at time 3. Propylparaben concentrations increased from 8.9ng/ml to 33.6ng/ml between time 1 and time 2 (p-value=0.005), followed by a decrease to 12.9ng/ml at time 3 (p-value=0.01). However, we cannot rule out the possibility that some of the observed differences are due to other sources of exposure to these compounds.
While additional research is needed, this pilot study potentially identifies a previously unknown source of phthalate and paraben exposure among pregnant women undergoing routine ultrasound examination.
在涂抹身体乳液后,邻苯二甲酸盐和对羟基苯甲酸酯会被人体系统吸收,并且已确认静脉输液袋和输液管等医疗设备是邻苯二甲酸二(2-乙基己基)酯(DEHP)的暴露源。然而,孕期产科超声检查中使用的水性凝胶等医疗程序中所使用产品作为内分泌干扰物化学物质(EDC)潜在暴露源的情况尚未得到研究。人体研究已将EDC与各种不良妊娠结局联系起来。有必要确定无意中接触EDC的来源,尤其是在孕期等脆弱的发育阶段。
我们开展了一项初步研究,以确定在常规产科超声检查中使用凝胶是否会增加邻苯二甲酸盐和苯酚生物标志物的尿液浓度。
我们从马萨诸塞州总医院招募了13名女性,她们在孕中期进行解剖学超声检查时提供了即时尿样。第一个样本在检查前(暴露前,时间1)采集,另外两个样本在扫描后的暴露后约1-2小时(时间2)和7-12小时(时间3)采集。
几种DEHP代谢物和二异壬基环己烷-1,2-二羧酸酯(DINCH)代谢物的尿液浓度随时间增加。例如,邻苯二甲酸单(2-乙基-5-羟基己基)酯的几何平均浓度在时间1和时间3之间从3.1纳克/毫升增加到7.1纳克/毫升(p值=0.03)。我们还观察到邻苯二甲酸丁苄酯(BBzP)、邻苯二甲酸二正丁酯(DnBP)和邻苯二甲酸二异丁酯(DiBP)代谢物浓度存在显著差异。例如,邻苯二甲酸单正丁酯(DnBP的代谢物)在时间1和时间2之间从3.5纳克/毫升降至1.8纳克/毫升(p值=0.04),但在时间3时又升至6.6纳克/毫升(p值=0.002)。对羟基苯甲酸丙酯浓度在时间1和时间2之间从8.9纳克/毫升增加到33.6纳克/毫升(p值=0.005),随后在时间3降至12.9纳克/毫升(p值=0.01)。然而,我们不能排除观察到的一些差异是由于这些化合物的其他暴露源所致的可能性。
虽然还需要进一步研究,但这项初步研究可能确定了在接受常规超声检查的孕妇中,邻苯二甲酸盐和对羟基苯甲酸酯暴露的一个此前未知的来源。